Liuxun Li

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 6

Top Topics

Prostate Cancer

Silver Nanoparticles

Sensitive Detection

Top Venues

Molecules (Basel, Switzerland)

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Materials (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Guiyin Li, Bo Wang, Ling Li, Xinhao Li, Ruijie Yan, Jintao Liang, Xinchun Zhou, Liuxun Li, Zhide Zhou
H-rGO-Pd NPs Nanozyme Enhanced Silver Deposition Strategy for Electrochemical Detection of Glypican-3. Molecules (Basel, Switzerland) 28 (5) (2023)
Guiyin Li, Bo Wang, Ling Li, Xinhao Li, Ruijie Yan, Jintao Liang, Xinchun Zhou, Liuxun Li, Zhide Zhou
H-rGO-Pd NPs Nanozyme Enhanced Silver Deposition Strategy for Electrochemical Detection of Glypican-3. Molecules (Basel, Switzerland) 28 (5) (2023)
Guiyin Li, Zhide Zhou, Zhongmin Wang, Shiwei Chen, Jintao Liang, Xiaoqing Yao, Liuxun Li
An Efficient Electrochemical Biosensor to Determine 1,5-Anhydroglucitol with Persimmon-Tannin-Reduced Graphene Oxide-PtPd Nanocomposites. Materials (Basel, Switzerland) 16 (7) (2023)
Guiyin Li, Bo Wang, Ling Li, Xinhao Li, Ruijie Yan, Jintao Liang, Xinchun Zhou, Liuxun Li, Zhide Zhou
H-rGO-Pd NPs Nanozyme Enhanced Silver Deposition Strategy for Electrochemical Detection of Glypican-3. Molecules (Basel, Switzerland) 28 (5) (2023)
Guiyin Li, Bo Wang, Ling Li, Xinhao Li, Ruijie Yan, Jintao Liang, Xinchun Zhou, Liuxun Li, Zhide Zhou
H-rGO-Pd NPs Nanozyme Enhanced Silver Deposition Strategy for Electrochemical Detection of Glypican-3. Molecules (Basel, Switzerland) 28 (5) (2023)
Liuxun Li, Jiangli Xu
The androgen receptor-targeted proteolysis targeting chimera and other alternative therapeutic choices in overcoming the resistance to androgen deprivation treatment in prostate cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2022)